Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide versus CPAP in obstructive sleep apnoea with overweight/obesity
NCT07846865Phase 3Not yet recruiting
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 3 trial of tirzepatide in obstructive sleep apnea (OSA), sponsored by Woolcock Institute of Medical Research. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT07846865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07846865.